- Australian HR technology success stories CVCheck and LiveHire execute technology integration, broadening CVCheck’s addressable market.
- CVCheck is an expanding world-class online platform-as-a-service business and LiveHire is a high-growth talent acquisition & engagement services provider.
- Marketing and Client success teams of both parties working on the launch.
- Phase 2 of the CVCheck/ Xref platform integration released into the live production environment.
Background screening and verification company, CV Check Ltd (ASX: CV1) and LiveHire Limited (ASX: LVH), the talent acquisition & engagement platform company, have collaborated to live launch their technology integration, combining forces of two Australian HR technology success stories.
CVCheck and LiveHire Technology Integration
CVCheck is an expanding world-class online platform-as-a-service business with growing revenue streams through the provision of its background screening solutions for employers, small and medium enterprises (SMEs), industry associations and individuals worldwide. Over the years, the Company has upgraded and introduced innovations in its technology platform to optimise client satisfaction based on feedback, which helps in keeping the services relevant in a rapidly evolving world.
The Comprehensive Suite of Checks offered by CVCheck are listed below.
Source: Company Website
As a high-growth business in the HR technology sector space, LiveHires talent acquisition & engagement software offers a proactive sourcing and talent mobility solution called Live Talent Communities, which is aimed at delivering improvements in the flow of talent into and through a business.
The successful integration has seen the technology teams of both companies successfully collaborate to develop a seamless user interface and customer launch is underway. Now, clients would be able to request for using CVChecks solutions on LiveHire?s platform, creating an elegant end-to-end, full-service background screening solution which would support customers in procuring verification checks from around the world.
Furthermore, communications of the integration launch are already taking place under the supervisions and management of the marketing and client success teams at both companies.
The collaboration has presented an ideal opportunity to showcase the outstanding Australian HR technology community once again.
CVCheck and Xref Strategic Alliance Phase 2 Integration
CVCheck has also announced that Phase 2 of the CVCheck/ Xref platform integration has been completed and released into the live production environment.
Xref and CVCheck had formed a strategic alliance in November 2019 which was forged with the ?perspective of offering the best-of-breed solution for all candidate verification across Australia and New Zealand, following repeated demand by the customers.
Subsequently, Phase 1 of the CVCheck/ Xref platform integration was completed and went live in February 2020 with revenues booked ever since by both CVCheck and Xref.
Now, Phase 2 of the CVCheck/ Xref platform integration would allow CVCheck clients to order Xref reference checks directly from the CVCheck portal, or via any existing CVCheck integration or connector with other major human resource information systems (such as LiveHire, PageUp People, JobAdder, LinkedIn Talent Hub, SAP SuccessFactors, SmartRecruiters and more).
?CV1 continues to broaden its addressable market through expanding its ecosystem and customer take up with each new HR technology partner integration. CVCheck, LiveHire and Xref deliver very high-quality technology that is designed to delight our customers. I?m thrilled with how the respective teams have embraced collaborating to bring mutual benefit to all three client bases.?- Rod Sherwood, CVCheck CEO
- Background Verification Company, CVCheck Integrates with LinkedIn Talent Hub; Stock Up 16.67%
- CVCheck updates on a strong Q3FY20, Covid-19 Austerity Measures & Director Resignation
Stock Information: The CV1 stock settled the day?s trade on 26 May 2020 at AU$ 0.087, up 1.16% by AU$ 0.01. Over the last one month, CV1 has generated a positive return of 24.64%.
With the pandemic continuing to affect the globe, healthcare companies are evaluating their lead compounds for COVID-19 treatment. Future revenue for these stocks depends on the probability of launching an approved treatment in the market.